Primary fallopian tube carcinoma: A retrospective multicenter study

Purpose: This retrospective multicenter study aimed to assess the survival and prognostic factors of primary fallopian tube carcinoma.

Methods: The medical records of 29 patients with fallopian tube carcinoma from two centers were reviewed for age, stage, surgical intervention, relapse and survival.

Results: The mean age of the patients was 56 years (range, 37-76). Six patients were in Stage I (20.7%), eight cases in Stage II (27.6%), nine cases in Stage III (31%) and two cases in Stage IV (6.9%). Data on stage was not available in four cases (13.8). Fifteen patients underwent lymph node evaluation. The median follow-up was 29 months (range, 3-122). The median survival was 95 months with a 5-year survival rate of 69.7%. The median progression-free survival was 76 months with a 5-year survival rate of 51.8%.

Conclusion: Age, stage and lymphadenectomy were found to be significant prognostic factors on overall survival.

Fallopian tube carcinoma; Surgery; Chemotherapy

[1] Hu C.T.M., Hertig A.: "Primary carcinoma of the fallopian tube" Am. J. Obstet. Gynecol., 1950, 59, 58.

[2] Klein M., Rosen A., Graf A., Lahousen M., Kucera H., Pakisch B., et al.: "Primary fallopian tube carcinoma: a retrospective survey of 51 cases. Austrian Cooperative Study Group for Fallopian Tube Carcinoma". Arch. Gynecol. Obstet., 1994, 255 (3), 141.

[3] Gadducci A., Landoni F., Sartori E., Maggino T., Zola P., Gabriele A. et al.: "Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study". Gynecol. Oneal., 2001, 81 (2), 150.

[4] Vaughan M.M., Evans B.D., Baranyai J., Weitzer M.J.: "Survival of patients with primary fallopian tube carcinoma". Int. J. Gynecol. Cancer, 1998, 8 (1), 16.

[5] Rabczynski J., Ziolkowski P.: "Primary endometrioid carcmoma of fallopian tube. Clinicomorphologic study". Pathol. Oneal. Res., 1999, 5 (1), 61.

[6] Subramauyam B.R., Raghavendra B.N., Whalen C.A., Yee J.: "Ultrasonic features of fallopian tube carcinoma". J. Ultrasound Med., 1984, 3 (9), 391.

[7] Ajjimakorn S., Bhamarapravati Y., Israngura N.: "Ultrasound appearance of fallopian tube carcinoma". J. Clin. Ultrasound, 1988, 16 (7), 516.

[8] Kol S., Gal D.. Friedman M., Paldi E.: "Preoperative diagnosis of fallopian tube carcinoma by transvaginal sonography and CA- 125". Gynecol. Oneal., 1990, 37 (1), 129.

[9] Kurjak A., Kupesic S., Ilijas M., Sparac V., Kosuta D.: "Preoperative diagnosis of primary fallopian tube carcinoma". Gynecol Oncol., 1998, 68 (1), 29.

[10] Baekelandt M., Kockx M., Wesling F., Gerris J.: "Primary adenocarcinoma of the fallopian tube. Review of the literature". Int. J. Gynecol. Cancer, 1993, 3 (2), 65.

[11] Eddy G.L., Copeland L.J., Gershenson D.M., Atkinson E.N., Wharton J.T., Rutledge F.N.: "Fallopian tube carcinoma". Obstet Gynecol., 1984, 64 (4), 546.

[12] Baekelandt M., Jorunn Nesbakken A., Kristensen G.B., Trope C.G., Abeler V.M.: "Carcinoma of the fallopian tube". Cancer, 2000, 89 (10), 2076

[13] Kosary C., Trimble E.L.:'Treatment and survival for women with Fallopian tube carcinoma: a population-based study". Gynecol Oneal., 2002, 86 (2), 190.

[14] Alvarado-Cabrero I., Young R.H., Vamvakas E.C., Scully R.E.: "Carcinoma of the fallopian tube: a clinicopathological study of 105 cases with observations on staging and prognostic factors. Gynecol. Oneal., 1999, 72 (3), 367.

[15] Denham J.W., Maclennan K.A.: "The management of primary carcinoma of the fallopian tube. Experience of 40 cases". Cancer, 1984, 53 (1), 166.

[16] Wolfson A.H., Tralins K.S., Greven K.M., Kim R.Y., Corn B.W., Kuettel M.R. et al.: "Adenocarcinoma of the fallopian tube: results of a multi-institutional retrospective analysis of 72 patients". int. J. Radiat. Oneal. Biol. Phys., 1998, 40 (1), 71.

[17] Hellstrom A.C., Silfversward C., Nilsson B., Pettersson F.: "Carcinoma of the fallopian tube. A clinical and histopathologic review. T he Radiumhemmet series". Int. J. Gynecol. Cancer, 1994, 4 (6), 395.

[18] Peters W.A., 3'', Andersen W.A., Hopkins M.P., Kumar N.B., Morley G.W.: "Prognostic features of carcinoma of the fallopian tube". Obstet. Gynecol., 1988, 71 (5), 757.

[19] Rosen A.C., Ausch C., Hafner E., Klein M., Lahousen M., Graf A.H. et al.: "A 15 -year overview of management and prognosis in primary fallopian tube carcinoma. Austrian Cooperative Study Group for Fallopian Tube Carcinoma". Eur. J. Cancer, 1998, 34(11), 1725.

[20] di Re E., Grosso G., Raspagliesi F., Baiocchi G.: "Fallopian tube cancer: incidence and role of lymphatic spread". Gynecol. Oneal., 1996, 62 (2), 199.

[21] Gemignani M.L., Hensley M.L., Cohen R., Venkatraman E., Saigo P.E., Barakat R.R.: "Paclitaxel-based chemotherapy in carcinoma of the fallopian tube". Gynecol. Oneal., 2001, 80 (1), 16.

[22] Tresukosol D., Kudelka A.P., Edwards C.L., Fromm G.L., Mante R., Kavanagh J.J.: "Primary fallopian tube adenocarcinoma: clinical complete response after salvage treatment with high-dose paclitaxel". Gynecol. Oneal., 1995, 58 (2), 258.

[23] Gore M.E., Levy V., Rustin G., Perren T., Calvert A.H., Earl H. et al.: "Paclitaxel (Taxol) in relapsed and refractory ovarian cancer: the UK and Eire experience". Br. J. Cancer, 1995, 72 (4), 1016.